Phase 2 Study of Erlotinib in Combination With Linsitinib...

  • Main
  • 2016 / 8
  • Phase 2 Study of Erlotinib in Combination With Linsitinib...
Clinical Lung Cancer 2016 / 8

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations

Leighl, Natasha B., Rizvi, Naiyer A., de Lima, Lopes Gilberto, Arpornwirat, Wichit, Rudin, Charles M., Chiappori, Alberto A., Ahn, Myung-Ju, Chow, Laura Q.M., Bazhenova, Lyudmila, Dechaphunkul, Arunee
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2016.07.007
Date:
August, 2016
File:
PDF, 507 KB
english, 2016
Conversion to is in progress
Conversion to is failed